Investigators sought to determine the association between smoking and headache.
Abstinent smokers may have reduced preoperative pain tolerance and increased postoperative opioid use compared with nonsmokers.
A physician's insights on the growing vape market and whether or not vaping is a better option for smoking cessation.
This article discusses the most prevalent risk factors, as well as the clinical signs and symptoms, associated with RA.
This study also suggests that genetic factors, environmental factors and inflammation are independent predictors of radiographic progression in the SI joint in early axial SpA.
Age and cigarette smoking are associated with inflammatory joint signs in a high-risk cohort of RA first-degree relatives.
Smoking and the intense headaches could work together to cause vascular changes within the body, potentially interrupting blood supply to the brain, according to the study, published today in the journal Neurology.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds